-
- Service Offerings
- Managed Market Analysis
- Education and Training
- Competitive Intelligence
- Expanded Access
- Case Studies
- Comparative Effectiveness Review - Diabetes
- Expanded Access
- Comparative Cost Analysis - Pharmaceuticals
- Healthcare Reform Analysis
- Health Technology Assessment - Oncology
- Reimbursement Call Center and Patient Assistance Program Design - Multiple Product Classes
- Reimbursement Training and Field Reimbursement Call Tracking Tool
- Competitive Intelligence - Urology
- Product Commercialization and Reimbursement Landscape Analysis - Oncology
- Clinical Services Evaluation - Specialty Pharmacy
- Commercialization Strategy - Deep Vein Thrombosis
- Coverage Analysis - Drug Delivery System
- Reimbursement Coverage and Coding Analysis - Vascular Stents
- Health Economic Analysis - Rheumatoid Arthritis
- Health Economics Analysis - Diabetes Mellitus Blood Glucose Monitoring
- Comprehensive Clinical Analysis and Clinical Protocol Design - Migrane
- Outcomes Research Plan - Gastroenterology
- Clinical Compendium and Gap Analysis - Pain Management
- Reimbursement Landscape Analysis - Rare Bleeding Disorders (Hemophilia)
- Disease Area Review and Burden of Illness Analysis - Oncology
- Hospital Inpatient Payor Claims Analysis - Hospital Acquired Infections
- Health Economic Analysis - Orthopedics
- Market Valuation - Opioids
- Meta Analysis - HIV (Human Immunodeficiency Virus)
- AMCP Dossier - Dermatology
- Competitive Intelligence - Infectious Diseases
- Competitive Intelligence - Contraception
- Reimbursement Landscape Analysis - Urology
- Health Economics Analysis - Crohn's Disease
- Comprehensive Reimbursement and Health Economic Analysis - Neurovascular Disease
- Patient Assistance Program Design - Insulin Products
- Health Technology Assessment - Wound Therapy System
Case Studies
Health Economics Analysis - Diabetes Mellitus Blood Glucose Monitoring
Insight
A global health care company recognized that their new technology needed an overall health economics strategy based on current methods utilized by public and commercial payors for determining cost-effectiveness to support the coverage decision making process for their product.
Strategy
The Aequitas Group developed a health economics model based on the intended use of the product and existing alternatives. In addition, a health economics protocol was developed to accompany the clinical protocol for the phase II analysis. Resource utilization data collected from this effort was used to populate the health economic model. Model results were incorporated in the presentation materials which were used for marketing and sales efforts.
Execution
A formal health economics analysis, using a Markov approach, was developed for the device. The incremental cost effectiveness was used to analyze potential health economics claims and aid in proposing revisions to the clinical study protocol. By determining that validated economic tools were needed to estimate the comparative clinical utility and total economic value of this product, The Aequitas Group was able to help payors understand the significant return on investment associated with the client’s products and this assisted the client in obtaining appropriate reimbursement.
© 2009 The Aequitas Group, Inc. All Rights Reserved.